| 1. |
- Adam, Meike, et al.
(författare)
-
Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy
- 2017
-
Ingår i: European Urology. - : Elsevier BV. - 0302-2838 .- 1873-7560. ; 71:3, s. 330-336
-
Tidskriftsartikel (refereegranskat)abstract
- Background: While the optimal use and timing of secondary therapy after radical prostatectomy (RP) remain controversial, there are limited data on patient-reported outcomes following multimodal therapy.Objective: To assess the impact of additional radiation therapy (RT) and/or androgen deprivation therapy (ADT) on urinary continence, potency, and quality of life (QoL) after RP.Design, setting, and participants: Among 13 150 men who underwent RP from 1992 to 2013, 905 received RP + RT, 407 RP + ADT and 688 RP + RT + ADT.Outcome measurements and statistical analyses: Urinary function, sexual function, and overall QoL were evaluated annually using self-administered validated questionnaires. Propensity score-matched and bootstrap analyses were performed, and the distributions for all functional outcomes were analyzed as a function of time after RP.Results and limitations: Patients who received RP + RT had a 4% higher overall incontinence rate 3 yr after surgery, and 1% higher rate for severe incontinence (> 3 pads/24 h) compared to matched RP-only patients. ADT further increased the overall and severe incontinence rates by 4% and 3%, respectively, compared to matched RP + RT patients. RP + RT was associated with an 18% lower rate of potency compared to RP alone, while RP + RT + ADT was associated with a further 17% reduction compared to RP + RT. Additional RT reduced QoL by 10% and additional ADT by a further 12% compared to RP only and RP + RT, respectively. The timing of RT after RP had no influence on continence, but adjuvant compared to salvage RT was associated with significantly lower potency (37% vs 45%), but higher QoL (60% vs 56%). Limitations of our study include the observational study design and potential for selection bias in the treatments received.Conclusions: Secondary RT and ADT after RP have an additive negative influence on urinary function, potency, and QoL. Patients with high-risk disease should be counseled before RP on the potential net impairment of functional outcomes due to multimodal treatment.Patient summary: Men with high-risk disease choosing surgery upfront should be counseled on the potential need for additional radiation and or androgen deprivation, and the potential net impairment of functional outcomes arising from multimodal treatment.
|
|
| 2. |
- Bartocci, Ezio, et al.
(författare)
-
TOOLympics 2019 : An overview of competitions in formal methods
- 2019
-
Ingår i: Tools and Algorithms for the Construction and Analysis of Systems. - Cham : Springer. - 9783030175016 ; , s. 3-24
-
Konferensbidrag (refereegranskat)abstract
- Evaluation of scientific contributions can be done in many different ways. For the various research communities working on the verification of systems (software, hardware, or the underlying involved mechanisms), it is important to bring together the community and to compare the state of the art, in order to identify progress of and new challenges in the research area. Competitions are a suitable way to do that.The first verification competition was created in 1992 (SAT competition), shortly followed by the CASC competition in 1996. Since the year 2000, the number of dedicated verification competitions is steadily increasing. Many of these events now happen regularly, gathering researchers that would like to understand how well their research prototypes work in practice. Scientific results have to be reproducible, and powerful computers are becoming cheaper and cheaper, thus, these competitions are becoming an important means for advancing research in verification technology.TOOLympics 2019 is an event to celebrate the achievements of the various competitions, and to understand their commonalities and differences. This volume is dedicated to the presentation of the 16 competitions that joined TOOLympics as part of the celebration of the 25?ℎ anniversary of the TACAS conference.
|
|
| 3. |
- Fischer, Stefanie, et al.
(författare)
-
Outcome of men with relapse after adjuvant carboplatin for clinical stage i seminoma
- 2017
-
Ingår i: Journal of Clinical Oncology. - 0732-183X. ; 35:2, s. 194-
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose Adjuvant carboplatin is one of three management strategies that may follow inguinal orchiectomy in clinical stage I seminoma. However, little is known about the outcome of patients who experience a relapse after such treatment. Patients and Methods Data from 185 patients who relapsed after adjuvant carboplatin between January 1987 and August 2013 at 31 centers/groups from 20 countries were collected and retrospectively analyzed. Primary outcomes were disease-free survival and overall survival. Secondary outcomes were time to, stage at, and treatment of relapse as well as rate of subsequent relapses. Results With a median follow-up of 53 months (95% CI, 48 to 60 months) the 5-year disease-free survival was 82% (95% CI, 77% to 89%), and the 5-year overall survival was 98% (95% CI, 95% to 100%). The median time from orchiectomy to relapse was 19 months (95% CI, 17 to 23 months); 15% (95% CI, 10% to 21%) of relapses occurred > 3 years after treatment. The majority of relapses were detected by computed tomography scan during routine follow-up, 98% in the International Germ Cell Cancer Collaborative Group good prognosis group. Chemotherapy was administered to 92% of patients, mostly as standard first-line treatment corresponding to stage; 8% of patients had additional local treatments. Only 28 patients experienced a second relapse. At last follow-up, 174 (94%) of 185 patients were alive without disease, and four patients with disease. Seven patients died, three of whom due to progressive disease. Conclusion Within the limitations of a retrospective analysis, the results suggest that the majority of patients who experience a relapse after adjuvant carboplatin for clinical stage I seminoma can be successfully treated with a cisplatin-based chemotherapy regimen adequate for stage. Because 15% of the relapses occurred > 3 years after adjuvant treatment, a minimum of 5 years follow-up is recommended.
|
|
| 4. |
- Kaufmann, Tobias, et al.
(författare)
-
Common brain disorders are associated with heritable patterns of apparent aging of the brain
- 2019
-
Ingår i: Nature Neuroscience. - : Nature Publishing Group. - 1097-6256 .- 1546-1726. ; 22:10, s. 1617-
-
Tidskriftsartikel (refereegranskat)abstract
- Common risk factors for psychiatric and other brain disorders are likely to converge on biological pathways influencing the development and maintenance of brain structure and function across life. Using structural MRI data from 45,615 individuals aged 3-96 years, we demonstrate distinct patterns of apparent brain aging in several brain disorders and reveal genetic pleiotropy between apparent brain aging in healthy individuals and common brain disorders.
|
|
| 5. |
- Schordan, Markus, et al.
(författare)
-
Evaluation and Reproducibility of Program Analysis and Verification (Track Introduction)
- 2016
-
Ingår i: Leveraging applications of formal methods, verification and validation. - Cham : Springer. - 9783319471662 - 9783319471655 ; , s. 191-194
-
Konferensbidrag (refereegranskat)abstract
- Manual inspection of complex software is costly and error prone. Techniques and tools that do not require manual inspection are in dire need as our software systems grow at a rapid rate. This track is concerned with the methods of comparative evaluation of program analyses and the tools that implement them. It also addresses the question how program properties that have been verified can be represented such that they remain reproducible and reusable as intermediate results for other analyses and verification phases. In particular, it is of interest how different tools can be combined to achieve better results than with only one of those tools alone.
|
|
| 6. |
- Schordan, Markus, et al.
(författare)
-
Evaluation and reproducibility of program analysis (Track Introduction)
- 2014
-
Ingår i: Leveraging Applications of Formal Methods, Verification and Validation. Specialized Techniques and Applications. - Berlin, Heidelberg : Springer. - 9783662452301 - 9783662452318 ; , s. 479-481
-
Konferensbidrag (refereegranskat)abstract
- Today’s popular languages have a large number of different language constructs and standardized library interfaces. The number is further increasing with every new language standard. Most published analyses therefore focus on a subset of such languages or define a language with a few essential constructs of interest. More recently, program-analysis competitions [4,6,7,1] aim to evaluate comparatively implemented analyses for a given set of benchmarks. The comparison of the analyses focuses on various aspects: (a) the quality of established structures and automata describing the behavior of the analyzed program, (b) the verification of various specified program properties, (c) the impact on a client analysis of particular interest, and (d) the impact of analysis precision on program optimizations.
|
|
